cardiac toxicity in patients with breast cancer
Published 3 years ago • 179 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
0:37
challenges hpcs face when monitoring for cardiotoxicity in patients with breast cancer
-
1:08
dr. muss discusses evaluating cardiac toxicity in patients with breast cancer
-
0:56
cardiovascular disease risk in patients with breast cancer
-
1:47
safe: cardiotoxicity prevention in breast cancer treated with anthracyclines and/or trastuzumab
-
0:41
improving cardiovascular health for patients with breast cancer
-
1:01
reducing the risk of cardiac radiation exposure in breast cancer
-
1:51
managing adc-related toxicity in breast cancer
-
0:15
together let's make zero deaths from breast cancer possible
-
55:08
cardiac toxicities of breast cancer treatment: pathophysiology, prevention, and treatment
-
2:01
beyond anthracyclines and trastuzumab: cardiotoxicity of novel agents
-
58:50
cardiac dysfunction in breast cancer patients: monitoring, diagnosis, and treatment
-
1:37
breast cancer: safe-heart study
-
1:19
real-world use of bevacizumab in patients with breast cancer
-
7:32
cardiac safety in the aphinity study
-
3:26
subgroup analysis from safe trial: pharmacological cardioprotective strategies for breast cancer
-
0:57
cardiovascular risk evaluation for breast cancer survivors: a pilot study
-
2:08
destiny-breast07: t-dxd /- pertuzumab in patients with metastatic her2 breast cancer
-
4:29
pertuzumab, trastuzumab and cyclophosphamide in older patients with her2 breast cancer
-
36:30
breast cancer & cardiovascular disease - the connection & how to reduce the burden